TG Therapeutics, Inc. (0VGI.L)

USD 31.97

(-5.69%)

Operating Income Summary of TG Therapeutics, Inc.

  • TG Therapeutics, Inc.'s latest annual operating income in 2023 was 20.63 Million USD , up 110.7% from previous year.
  • TG Therapeutics, Inc.'s latest quarterly operating income in 2024 Q2 was 8.81 Million USD , up 195.1% from previous quarter.
  • TG Therapeutics, Inc. reported an annual operating income of -192.83 Million USD in 2022, up 44.07% from previous year.
  • TG Therapeutics, Inc. reported an annual operating income of -344.77 Million USD in 2021, down -26.02% from previous year.
  • TG Therapeutics, Inc. reported a quarterly operating income of 8.81 Million USD for 2024 Q2, up 195.1% from previous quarter.
  • TG Therapeutics, Inc. reported a quarterly operating income of 12.43 Million USD for 2024 Q3, up 41.04% from previous quarter.

Annual Operating Income Chart of TG Therapeutics, Inc. (2023 - 1996)

Historical Annual Operating Income of TG Therapeutics, Inc. (2023 - 1996)

Year Operating Income Operating Income Growth
2023 20.63 Million USD 110.7%
2022 -192.83 Million USD 44.07%
2021 -344.77 Million USD -26.02%
2020 -273.59 Million USD -61.84%
2019 -169.05 Million USD 3.06%
2018 -174.4 Million USD -46.91%
2017 -118.71 Million USD -50.33%
2016 -78.96 Million USD -24.99%
2015 -63.18 Million USD -13.39%
2014 -55.72 Million USD -142.62%
2013 -22.96 Million USD 14.61%
2012 -26.89 Million USD -2949.42%
2011 -881.97 Thousand USD 56.27%
2010 -2.01 Million USD -13.84%
2009 -1.77 Million USD 59.85%
2008 -4.41 Million USD 63.66%
2007 -12.14 Million USD -21.44%
2006 -10 Million USD 48.34%
2005 -19.35 Million USD -215.12%
2004 -6.14 Million USD -29.1%
2003 -4.75 Million USD -206.41%
2002 -1.55 Million USD 50.02%
2001 -3.1 Million USD 1.74%
2000 -3.16 Million USD -17.13%
1999 -2.7 Million USD 0.0%
1998 -2.7 Million USD 49.06%
1997 -5.3 Million USD -39.47%
1996 -3.8 Million USD 0.0%

Peer Operating Income Comparison of TG Therapeutics, Inc.

Name Operating Income Operating Income Difference
Editas Medicine, Inc. -169.18 Million USD 112.196%
Dynavax Technologies Corporation -37.02 Million USD 155.723%
Cara Therapeutics, Inc. -121.49 Million USD 116.983%
Walgreens Boots Alliance, Inc. -14.07 Billion USD 100.147%
Supernus Pharmaceuticals, Inc. -5.26 Million USD 491.592%
Perrigo Company plc 151.9 Million USD 86.417%
Atara Biotherapeutics, Inc. -276 Million USD 107.476%
Illumina, Inc. -1.06 Billion USD 101.93%
Thermo Fisher Scientific Inc. 6.85 Billion USD 99.699%
Nektar Therapeutics -137.42 Million USD 115.014%
Iovance Biotherapeutics, Inc. -460.55 Million USD 104.48%
IQVIA Holdings Inc. 1.97 Billion USD 98.956%
Heron Therapeutics, Inc. -110.61 Million USD 118.653%
Unity Biotechnology, Inc. -44.66 Million USD 146.193%
BioMarin Pharmaceutical Inc. 194.44 Million USD 89.389%
Waters Corporation 817.67 Million USD 97.477%
Biogen Inc. 1.29 Billion USD 98.409%
Sangamo Therapeutics, Inc. -274 Million USD 107.53%
Adicet Bio, Inc. -152.03 Million USD 113.571%
Evolus, Inc. -49.23 Million USD 141.909%
bluebird bio, Inc. -244.26 Million USD 108.447%
Aclaris Therapeutics, Inc. -97.35 Million USD 121.193%
Esperion Therapeutics, Inc. -155.56 Million USD 113.263%
FibroGen, Inc. -281.81 Million USD 107.321%
Agilent Technologies, Inc. 1.35 Billion USD 98.472%
Homology Medicines, Inc. -48.25 Million USD 142.758%
Geron Corporation -193.94 Million USD 110.639%
Alnylam Pharmaceuticals, Inc. -282.17 Million USD 107.312%
Corbus Pharmaceuticals Holdings, Inc. -45.07 Million USD 145.772%
Amicus Therapeutics, Inc. -73.49 Million USD 128.074%
Myriad Genetics, Inc. -123.7 Million USD 116.68%
Regeneron Pharmaceuticals, Inc. 4.04 Billion USD 99.49%
OPKO Health, Inc. -157.02 Million USD 113.14%
Viking Therapeutics, Inc. -100.82 Million USD 120.464%
Intellia Therapeutics, Inc. -515.29 Million USD 104.004%
Zoetis Inc. 3.06 Billion USD 99.328%
Abeona Therapeutics Inc. -48.2 Million USD 142.807%
Mettler-Toledo International Inc. 1.08 Billion USD 98.102%
Exelixis, Inc. 170.88 Million USD 87.926%
Vertex Pharmaceuticals Incorporated 4.3 Billion USD 99.521%
uniQure N.V. -282.87 Million USD 107.294%
Kala Pharmaceuticals, Inc. -39.15 Million USD 152.698%
Anavex Life Sciences Corp. -55.75 Million USD 137.006%
Axsome Therapeutics, Inc. -231.82 Million USD 108.9%
Verastem, Inc. -92.08 Million USD 122.407%
Imunon, Inc. -21.03 Million USD 198.11%
Ionis Pharmaceuticals, Inc. -353.73 Million USD 105.833%
Sarepta Therapeutics, Inc. -267.82 Million USD 107.704%
Neurocrine Biosciences, Inc. 250.9 Million USD 91.776%
Corcept Therapeutics Incorporated 107.28 Million USD 80.768%
Halozyme Therapeutics, Inc. 337.57 Million USD 93.888%
Blueprint Medicines Corporation -486.27 Million USD 104.243%
Insmed Incorporated -709.62 Million USD 102.908%
Agios Pharmaceuticals, Inc. -391.48 Million USD 105.27%
Incyte Corporation 620.52 Million USD 96.675%
Emergent BioSolutions Inc. -726.4 Million USD 102.84%